Patent ID: 9090943
Filing Date: 2015-07-28
Classification: C12Q

Abstract:
1. A method for detecting a risk of developing breast or ovarian cancer in a human subject carrying a BRCA2 mutation comprising detecting a nucleic acid sequence of a polymorphism of a microRNA-related gene or variant thereof comprising SEQ ID NO: 1 by nucleic acid amplification or extension using any one of SEQ ID NO: 26, SEQ ID NO: 42 or SEQ ID NO: 58 as a primer, comparing the polymorphic pattern of the microRNA-related gene or variant thereof to a reference wild-type allele in a human subject not carrying the BRCA2 mutation, wherein the presence of a C/T heterozygote genotype at the rs11169571 SNP in said microRNA-related gene or variant thereof relative to the reference wild-type allele is indicative of an increased risk of developing breast or ovarian cancer in said human subject, and determining whether the human subject has an increased risk of developing breast or ovarian cancer based on the presence of the C/T heterozygote genotype at the rs11169571 SNP in the microRNA-related gene or variant thereof relative to the reference wild-type allele.